- Regional Directory
- Americas
- Analysis
- Asia Pacific
- Central Asia
- Eurasia
- Europe
- Middle East and North Africa
- South Asia
- South Pacific
- Sub-Saharan Africa
- United States
Vaccine Nationalism Is an Exaggerated Threat
Large pharmaceutical companies are multinational organizations with incentives to distribute their vaccines broadly.
Nationalism is all the rage these days. Following decades of globalization, the pendulum has begun to swing back the other direction, triggering fears that nationalist policies will lead to a breakdown in international cooperation and a destabilization of the world order. This, in turn, has led to much hand-wringing over “vaccine nationalism,” the notion that governments will take a “me first” approach to vaccines, further exacerbating the health crisis. The crux of the argument was elaborated in Harvard Business Review: “A [2009 H1N1 influenza] vaccine was developed within seven months, but most high-income countries turned to pharmaceutical companies within their own borders for production. High-income countries directly negotiated large advance orders for the vaccine, crowding out poor countries. Although several of those rich countries, including the United States, agreed to make vaccine donations to low- and middle-income countries, they only carried out these donations after ensuring they could cover their own populations first. As a result, the distribution of the H1N1 vaccine was based on high-income countries’ purchasing power, not the risk of transmission.” This argument is predicated on an idealized view of nation-state behavior. While it is true that it is preferable from a public health standpoint to provide […]